The association of oestrogen receptor alpha-haplotypes with cardiovascular risk factors in the British Women's Heart and Health Study
The association of oestrogen receptor alpha-haplotypes with cardiovascular risk factors in the British Women's Heart and Health Study
Aims One previous study among women with established coronary heart disease found a gene–treatment interaction between the oestrogen receptor gene (ESR1) and hormone replacement in their association with high density lipoprotein cholesterol (HDL-c). We aimed to replicate these findings in a general population sample.
Methods and results Cross-sectional associations were assessed in a study of 3404 women from 23 towns across Britain who were aged 60–79 at the time of assessment and were described as white by the examining nurse. Women with the T-A haplotype [constructed from two single nucleotide polymorphisms (SNPs) in the first intron of ESR1: c454-397T>C (rs2234693) and c454-351A>G (rs9340799)], which was predicted to be associated with reduced oestrogen response, were more likely to have been past [per haplotype odds ratio 1.16 (95% CI 1.01, 1.33), P = 0.02] or to be current users [per haplotype odds ratio 1.19 (95% CI 0.99, 1.42), P = 0.05] of hormone replacement. However, there was no association between haplotype or either SNP and HDL-c or other cardiovascular disease risk factors and no statistical evidence of an interaction between hormone replacement use and haplotype or either SNP with respect to HDL-c or any other cardiovascular disease risk factors.
Conclusion Women with the T-A haplotype are more likely to use hormone replacement. However, genotyping of ESR1 rs2234693 or rs9340799 in post-menopausal women to tailor hormone replacement is unlikely to markedly improve cardiovascular risk.
cholesterol, cardiovascular disease, insulin resistance, hormone replacement therapy, risk factors, aged, methods, research, metabolism, time, humans, genotype, research support
1597-1604
Lawlor, Debbie A.
799826df-f115-4fb7-83ea-53c246c220d4
Timpson, Nick
91f6a11f-f375-43d7-87f9-ede6f090f161
Ebrahim, Shah
0f2ade5c-4ef6-4ca7-9f9b-9b60ba192b13
Day, Ian N.M.
b749b30a-1f4c-40eb-af0e-a50427388b39
Smith, George Davey
f5bc8327-f2cb-49a0-8eae-4a6ba63207a2
21 March 2006
Lawlor, Debbie A.
799826df-f115-4fb7-83ea-53c246c220d4
Timpson, Nick
91f6a11f-f375-43d7-87f9-ede6f090f161
Ebrahim, Shah
0f2ade5c-4ef6-4ca7-9f9b-9b60ba192b13
Day, Ian N.M.
b749b30a-1f4c-40eb-af0e-a50427388b39
Smith, George Davey
f5bc8327-f2cb-49a0-8eae-4a6ba63207a2
Lawlor, Debbie A., Timpson, Nick, Ebrahim, Shah, Day, Ian N.M. and Smith, George Davey
(2006)
The association of oestrogen receptor alpha-haplotypes with cardiovascular risk factors in the British Women's Heart and Health Study.
European Heart Journal, 27 (13), .
(doi:10.1093/eurheartj/ehi833).
Abstract
Aims One previous study among women with established coronary heart disease found a gene–treatment interaction between the oestrogen receptor gene (ESR1) and hormone replacement in their association with high density lipoprotein cholesterol (HDL-c). We aimed to replicate these findings in a general population sample.
Methods and results Cross-sectional associations were assessed in a study of 3404 women from 23 towns across Britain who were aged 60–79 at the time of assessment and were described as white by the examining nurse. Women with the T-A haplotype [constructed from two single nucleotide polymorphisms (SNPs) in the first intron of ESR1: c454-397T>C (rs2234693) and c454-351A>G (rs9340799)], which was predicted to be associated with reduced oestrogen response, were more likely to have been past [per haplotype odds ratio 1.16 (95% CI 1.01, 1.33), P = 0.02] or to be current users [per haplotype odds ratio 1.19 (95% CI 0.99, 1.42), P = 0.05] of hormone replacement. However, there was no association between haplotype or either SNP and HDL-c or other cardiovascular disease risk factors and no statistical evidence of an interaction between hormone replacement use and haplotype or either SNP with respect to HDL-c or any other cardiovascular disease risk factors.
Conclusion Women with the T-A haplotype are more likely to use hormone replacement. However, genotyping of ESR1 rs2234693 or rs9340799 in post-menopausal women to tailor hormone replacement is unlikely to markedly improve cardiovascular risk.
This record has no associated files available for download.
More information
Published date: 21 March 2006
Keywords:
cholesterol, cardiovascular disease, insulin resistance, hormone replacement therapy, risk factors, aged, methods, research, metabolism, time, humans, genotype, research support
Identifiers
Local EPrints ID: 59971
URI: http://eprints.soton.ac.uk/id/eprint/59971
ISSN: 0195-668X
PURE UUID: 33391f23-f853-4cb4-9c9b-cf9e840d3f95
Catalogue record
Date deposited: 05 Sep 2008
Last modified: 15 Mar 2024 11:18
Export record
Altmetrics
Contributors
Author:
Debbie A. Lawlor
Author:
Nick Timpson
Author:
Shah Ebrahim
Author:
Ian N.M. Day
Author:
George Davey Smith
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics